Exact Sciences (EXAS) closed the newest buying and selling day at $96.47, transferring -0.94% from
Exact Sciences (EXAS) closed the newest buying and selling day at $96.47, transferring -0.94% from the earlier buying and selling session. This transfer lagged the S&P 500’s each day lack of 0.39%. On the similar time, the Dow misplaced 0.95%, and the tech-heavy Nasdaq misplaced 0.83%.
Previous to right now’s buying and selling, shares of the molecular diagnostics firm had misplaced 5.81% over the previous month. This has lagged the Medical sector’s lack of 1.06% and the S&P 500’s lack of 0.1% in that point.
Wall Road might be on the lookout for positivity from EXAS because it approaches its subsequent earnings report date. That is anticipated to be October 29, 2019. On that day, EXAS is projected to report earnings of -$0.41 per share, which might symbolize a year-over-year decline of 36.67%. In the meantime, our newest consensus estimate is asking for income of $216.40 million, up 82.94% from the prior-year quarter.
Wanting on the full yr, our Zacks Consensus Estimates counsel analysts expect earnings of -$1.75 per share and income of $810.11 million. These totals would mark adjustments of -28.68% and +78.26%, respectively, from final yr.
…